Eric Schmidt FCA
Stock Analyst at Cantor Fitzgerald
(4.87)
# 350
Out of 5,096 analysts
45
Total ratings
44.4%
Success rate
76.3%
Average return
Main Sectors:
Stocks Rated by Eric Schmidt FCA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETRA Electra Therapeutics | Initiated Coverage: Buy | n/a | $7.31 | - | 1 | Oct 13, 2026 | |
| FDMT 4D Molecular Therapeutics | Upgraded: Buy | n/a | $11.37 | - | 1 | Sep 21, 2026 | |
| DYN Dyne Therapeutics | Initiated Coverage: Buy | n/a | $17.30 | - | 1 | Jul 23, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | $206 | $249.01 | -17.27% | 4 | Jun 22, 2026 | |
| ODTX Odyssey Therapeutics | Initiated Coverage: Buy | n/a | $19.53 | - | 1 | Jun 2, 2026 | |
| LONA LeonaBio | Reiterated: Buy | n/a | $4.73 | - | 2 | Apr 7, 2026 | |
| GENB Generate Biomedicines | Initiated Coverage: Buy | n/a | $13.21 | - | 1 | Mar 24, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | n/a | $42.91 | - | 2 | Mar 19, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $75 → $74 | $21.10 | +250.71% | 4 | Dec 17, 2025 | |
| VSTM Verastem | Initiated Coverage: Buy | n/a | $9.59 | n/a | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.38 | n/a | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $75.00 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.31 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $14.80 | n/a | 8 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.41 | n/a | 1 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.29 | n/a | 2 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.06 | n/a | 3 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.95 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $12.91 | n/a | 1 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.54 | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $120.04 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $21.76 | n/a | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $29.79 | n/a | 1 | Nov 2, 2023 |
Electra Therapeutics
Oct 13, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $7.31
Upside: -
4D Molecular Therapeutics
Sep 21, 2026
Upgraded: Buy
Price Target: n/a
Current: $11.37
Upside: -
Dyne Therapeutics
Jul 23, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $17.30
Upside: -
Biogen
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $206
Current: $249.01
Upside: -17.27%
Odyssey Therapeutics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $19.53
Upside: -
LeonaBio
Apr 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.73
Upside: -
Generate Biomedicines
Mar 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $13.21
Upside: -
Scholar Rock Holding
Mar 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $42.91
Upside: -
Legend Biotech
Dec 17, 2025
Reiterated: Buy
Price Target: $75 → $74
Current: $21.10
Upside: +250.71%
Verastem
Oct 16, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $9.59
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $6.38
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $75.00
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $2.31
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $14.80
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $28.41
Upside: n/a
Jun 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.29
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.06
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $29.95
Upside: n/a
Mar 21, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $12.91
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $1.54
Upside: n/a
Apr 23, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $120.04
Upside: n/a
Apr 4, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $21.76
Upside: n/a
Nov 2, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $29.79
Upside: n/a